In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
HIV policies at the Peace Corps come under fire.
Curing hepatitis C is a priority for people also living with HIV.
This quick-reference chart compares available medication options, including adult dosing and dietary restrictions.
This treatment-themed special issue of POZ spotlights several issues that have evolved over the years.
Understanding the importance of basic HIV research and clinical trials—and the benefits of being undetectable
Whether you’re sunning on the beach or snuggling in bed, these books will shine through the whole season.
The fight to protect trans health care from discrimination
Record your HIV story with a free 30-day journal.
POZ.com excerpted the annual letter from the International AIDS Society (IAS) as an opinion piece. Below is an edited version.
An opinion piece titled “HIV-Free Generation in Striking Distance, but Not For All,” by Chad Hendry and Liz Thompson.
Here are some important dates in AIDS history.
Some featured responses and reactions to Mark S. King’s essay in our June issue.
Those resistant to both of the medications in Truvada are rare.
Sustiva was connected to a 3.3-fold greater risk of suicidal behaviors in a new analysis.
Findings provide reassurance on ethics of cure studies.
According to the CDC, the national annual HIV infection rate has dropped by 15 percent.
More of those living with HIV are developing diabetes.
The FDA approves three new, cheaper combination ARV tablets.
Menopause in women living with HIV can worsen pain.
Researchers advocate prescribing DAAs during the early phases of hep C infection for those coinfected with HIV.
Nelson Vergel pushes for the development of new salvage therapies.